Preparation method of ticagrelor and intermediates thereof

• US 9,604,991 B2
• Filed: 12/20/2015
• Issued: 03/28/2017
• Est. Priority Date: 06/24/2013
• Status: Active Grant

• Current Assignee: Suzhou Miracpharma Technology Co., Ltd
• Original Assignee: Suzhou Miracpharma Technology Co., Ltd
• Inventors: Xu, Xuenong
• Primary Examiner(s): Murray, Jeffrey H
• Application Number:
  US14/975,785
• Publication Number:
  US 20160102101A1
• Time in Patent Office: 464 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: C07D 317/44 ortho- or peri-condensed with carbocyclic rings or ring systems
• CPC Class Codes: C07D 405/04 directly linked by a ring-member-to-ring-member bond
• CPC Class Codes: C07D 487/04 Ortho-condensed systems

Abstract

Disclosed in the present invention is a method for preparing Ticagrelor (I), comprising the following steps: a cyclization reaction of 5-amino-1,4-di-substituted-1,2,3-triazole (II) and dialkyl carbonate (HI), to obtain 9-substituted-2,6-dihydroxy-8-azapurine (IV); chlorination of intermediate (IV), to obtain 9-substituted-2,6-dichloro-8-azapurine (V); an amination reaction of intermediate (V) and trans-(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine (VI) generates 9-substituted-6-amino-substituted-2-chloro-8-azapurine (VII); and a propanethiolation reaction of intermediate (VII) and propanethiol (VIII), to obtain Ticagrelor (I). The preparation method is simple in process, has a high chemical and chiral purity and provides a new preparation method for industrializing Ticagrelor. In addition, also provided in the present invention are intermediates of Ticagrelor and a preparation method thereof, wherein raw materials of the preparation method are easily available, the conditions thereof are mild, and the yield thereof is high.

Claims

1. A method for preparing Ticagrelor(I),

2. The method for preparing Ticagrelor according to claim 1, wherein the preparation of 5-amino-1, 4-disubstituted-1, the preparation of 2,3-triazole (II) comprises the following steps:

cyclization reaction of azide compound (IX) and cyano derivative (X), to obtain 5-amino-1, 4-di-substituted-1, 2,3-triazole (II);

Wherein the feeding ratio of azide compound (IX) to cyano derivative (X) is 1;

1-5;

wherein cyano derivative (X) is 2-cyanoacetamide, 2-cyanoacetic acid, malononitrile or 2-cyano alkyl acetate.

3. The method for preparing Ticagrelor according to claim 2, wherein an alkali accelerator used in cyclization reaction is sodium hydride, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium tert-butoxide, potassium carbonate, triethylamine, pyridine, 2,6-lutidine, 4-dimethylaminopyridine, N-methylmorpholine, N-ethylmorpholine, diisopropylethylamine, 1,5-diazabicyclo [4.3.0]-non-5-ene, 1,8-diazabicyclo[5.4.0]-undec-7-ene or 1,4-diazabicyclo [2.2.2]octane;

and a solvent used in the cyclization reaction is dichloromethane, chloroform, 1,2-dichloroethane, toluene, acetonitrile, tetrahydrofuran, methanol, ethanol, isopropanol, 1,2-dioxane, or tetrahydrofuran.

4. The method for preparing Ticagrelor according to claim 2, wherein the chemical name of azide compound (IX) is 1-alkoxy-substituted-2,3-acetone protected o-hydroxy-4-azido-cyclopentane, and the chemical formula is shown as the formula (IX) below:

5. The method for preparing Ticagrelor according to claim 2, wherein four prochiral carbon atoms in the azide compound (IX) can be single R configuration, single S configuration or its racemate.

6. The method for preparing Ticagrelor according to claim 2, wherein the azide reagent (XII) is sodium azide, hydrazoic acid, imidazole azide sulfonyl, trifluoromethanesulfonyl azide, p-toluenesulfonyl azide, methanesulfonyl azide or trimethylsilyl azide.

7. The method for preparing Ticagrelor according to claim 2, wherein a feeding molar ratio of amino compound (XI) to azide reagent (XII) is 1:

1-5 in the azido reaction;

wherein an alkali accelerator used in the azido reaction is sodium hydride, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium tert-butoxide, potassium carbonate, triethylamine, pyridine, 2,6-lutidine, 4-dimethylaminopyridine, N-methylmorpholine, N-ethylmorpholine, diisopropylethylamine, 1,5-diazabicyclo bicyclo [4.3.0]-non-5-ene, 1,8-diazabicyclo [5.4.0]-undec-7-ene or 1,4-diazabicyclo [2.2.2]octane;

wherein the catalyst used for azido reaction can be selected from copper chloride, nickel chloride, cobaltous chloride(II), zinc chloride, copper sulfate, nickel sulfate, cobaltous sulphate(II) or zinc sulfate;

wherein a solvent used in azido reaction can be dichloromethane, chloroform, 1,2-dichloroethane, toluene, acetonitrile, tetrahydrofuran, methanol, ethanol, isopropanol, 1,2-dioxane or tetrahydrofuran.

8. The method for preparing Ticagrelor according to claim 1, wherein:

an alkali accelerator used in the cyclization reaction is sodium, sodium hydride, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium tert-butoxide, potassium carbonate, potassium hydroxide or sodium hydroxide.

9. The method for preparing Ticagrelor according to claim 1, wherein a chlorinating agent used in chlorination reaction is phosphorus oxychloride, phosphorus trichloride, phosphorus pentachloride, oxalyl chloride, thionyl chloride, benzoyl chloride, phthaloyl chloride, pivaloyl chloride or thionyl chloride.

10. The method for preparing Ticagrelor according to claim 1, wherein an acid-binding agents used in chlorination reaction is triethylamine, pyridine, 2,6-lutidine, 4-dimethylaminopyridine, N-methylmorpholine, N-ethylmorpholine, diisopropylethylamine, 1,5-diazabicyclo [4.3.0]-non-5-ene, 1,8-diazabicyclo [5.4.0]-undec-7-ene or 1,4-diazabicyclo [2.2.2]octane.

11. The method for preparing Ticagrelor according to claim 1, wherein a feeding molar ratio of 9-substituted-6-amino-substituted-2-chloro-8-azapurine (VII) to propanethiol (VIII) is 1:

1-2.0;

wherein an alkali accelerator used in propanethiolation reaction is sodium hydride, sodium methoxide, sodium ethoxide, potassium t-butoxide, potassium carbonate, cesium carbonate, sodium hydroxide, potassium hydroxide, sodium amide, sodium bis(trimethylsilyl)amide, potassium bis(trimethylsily)amide, lithium bis(trimethylsily)amide or lithium diisopropylamide.